会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 36. 发明申请
    • SELF-ASSEMBLING PEPTIDES, PEPTIDE NANOSTRUCTURES AND USES THEREOF
    • 自组装肽,肽类纳米结构及其用途
    • WO2014014613A3
    • 2014-05-01
    • PCT/US2013046821
    • 2013-06-20
    • HARVARD COLLEGE
    • INGBER DONALD EROBERTS KENNY
    • C07K7/06C07K7/08C07K14/00
    • C07K14/78A61K9/1658A61K47/48246A61K47/64C07K14/001
    • Provided herein relates to self-assembling peptides and various nanostructures self-assembled from the isolated peptides. In some embodiments, the self-assembling peptides can form a nanostructure, e.g., a nanoparticle or microparticle, for use in various biomedical applications such as drug delivery or tissue engineering. In some embodiments, the nanostructures can comprise an agent, e.g., a biological molecule. The agent can be encapsulated or entrapped in the nanostructures during formation of the nanostructures. Alternatively or additionally, the agent can be integrated directly or indirectly (e.g., via a linker or a conjugation or crosslinking agent) to the self-assembling peptide structure, prior to formation of the nanostructures. In some embodiments where the agent is a peptide-based agent, unitary peptide nanostructures, rather than nanoparticles that are formed and later covalently modified, can be generated.
    • 本文涉及自组装肽和从分离的肽自组装的各种纳米结构。 在一些实施方案中,自组装肽可以形成用于各种生物医学应用如药物递送或组织工程的纳米结构,例如纳米颗粒或微粒。 在一些实施方案中,纳米结构可以包含试剂,例如生物分子。 在形成纳米结构期间,该试剂可被包封或包埋在纳米结构中。 或者或另外,在形成纳米结构之前,可将试剂直接或间接(例如经由接头或共轭或交联剂)整合至自组装肽结构。 在其中试剂是基于肽的试剂的一些实施方案中,可以产生单一肽纳米结构,而不是形成和随后共价修饰的纳米颗粒。